Recombinant multi-species Syntaxin 18/STX18 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Syntaxin 18/STX18 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the syntaxin family of soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) which is part of a membrane tethering complex that includes other SNAREs and several peripheral membrane proteins, and is involved in vesicular transport between the endoplasmic reticulum (ER) and the Golgi complex. The encoded protein is important for the organization of the smooth, rough, and exit site ER subdomains. A pseudogene of this gene has been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
The Alternative Names of target: 1810035L21Rik,4933425D03Rik,Cell growth-inhibiting gene 9 protein,STX18,Stx18,Syntaxin 18,Syntaxin-18,Ufe1

Target products collectionGo to Syntaxin 18/STX18 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1850-Ag-1/ GM-Tg-hg-IP1850-Ag-2 Human Syntaxin 18/STX18 protein Human
GM-Tg-rg-IP1850-Ag-1/ GM-Tg-rg-IP1850-Ag-2 Rat Syntaxin 18/STX18 protein Rat
GM-Tg-mg-IP1850-Ag-1/ GM-Tg-mg-IP1850-Ag-2 Mouse Syntaxin 18/STX18 protein Mouse
GM-Tg-cynog-IP1850-Ag-1/ GM-Tg-cynog-IP1850-Ag-2 Cynomolgus/Rhesus macaque Syntaxin 18/STX18 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1850-Ag-1/ GM-Tg-felg-IP1850-Ag-2 Feline Syntaxin 18/STX18 protein Feline
GM-Tg-cang-IP1850-Ag-1/ GM-Tg-cang-IP1850-Ag-2 Canine Syntaxin 18/STX18 protein Canine
GM-Tg-bovg-IP1850-Ag-1/ GM-Tg-bovg-IP1850-Ag-2 Bovine Syntaxin 18/STX18 protein Bovine
GM-Tg-equg-IP1850-Ag-1/ GM-Tg-equg-IP1850-Ag-2 Equine Syntaxin 18/STX18 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1850-Ag-1/ GM-Tg-hg-IP1850-Ag-2; GM-Tg-rg-IP1850-Ag-1/ GM-Tg-rg-IP1850-Ag-2;
GM-Tg-mg-IP1850-Ag-1/ GM-Tg-mg-IP1850-Ag-2; GM-Tg-cynog-IP1850-Ag-1/ GM-Tg-cynog-IP1850-Ag-2;
GM-Tg-felg-IP1850-Ag-1/ GM-Tg-felg-IP1850-Ag-2; GM-Tg-cang-IP1850-Ag-1/ GM-Tg-cang-IP1850-Ag-2;
GM-Tg-bovg-IP1850-Ag-1/ GM-Tg-bovg-IP1850-Ag-2; GM-Tg-equg-IP1850-Ag-1/ GM-Tg-equg-IP1850-Ag-2
Products Name Syntaxin 18/STX18 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Syntaxin 18/STX18
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Syntaxin 18/STX18 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.